The origin and future of oxidative stress pathology: From the recognition of carcinogenesis as an iron addiction with ferroptosis-resistance to non-thermal plasma therapy

Pathology International

Volumn 66, Issue 5, 2016, Pages 245-259

  Toyokuni, Shinya ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Carcinogenesis; Free radicals; Iron; Monoclonal antibody; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ASBESTOS; CHRYSOTILE; IRON; MULTI WALLED NANOTUBE; NITRILOTRIACETATE IRON; REACTIVE OXYGEN METABOLITE;

ATHEROSCLEROSIS; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; FERROPTOSIS; GENOME; HUMAN; KIDNEY CANCER; MESOTHELIOMA; NONHUMAN; OXIDATIVE STRESS; PLASMA GAS; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE MODEL; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT;

ANIMALS; CARCINOGENESIS; DISEASE MODELS, ANIMAL; HUMANS; IRON; OXIDATIVE STRESS; RATS;

EID: 84959509745     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12396     Document Type: Review

References (150)

1. Mojzsis S, Arrhenius G, McKeegan K, Harrison T, Nutman A, Friend C. Evidence for life on Earth before 3, 800 million years ago. Nature 1996; 384: 55.
2. Lyons TW, Reinhard CT, Planavsky NJ. The rise of oxygen in Earth/'s early ocean and atmosphere. Nature 2014; 506: 307-15.
3. Bau M, Möller P. Rare earth element systematics of the chemically precipitated component in Early Precambrian iron formations and the evolution of the terrestrial atmosphere-hydrosphere-lithosphere system. Geochim Cosmochim Acta 1993; 57: 2239-49.
4. Dismukes G, Klimov V, Baranov S, Kozlov YN, DasGupta J, Tyryshkin A. The origin of atmospheric oxygen on Earth: the innovation of oxygenic photosynthesis. Proc Natl Acad Sci U S A 2001; 98: 2170-5.
5. Marchetti C Energy systems-the broader context. Technol Forecast Soc 1979; 14: 191-203.
6. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 4 edn. New York: Oxford University Press 2007.
7. Ozasa K, Shimizu Y, Suyama A et al. Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res 2011; 177: 229-43.
8. Harman D Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300.
9. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-55.
10. Sies H. Oxidative Stress. New York; Academic Press, 1985.
11. Sies H Oxidative stress: A concept in redox biology and medicine. Redox Biol 2015; 4: 180-3.
12. Cadenas E, Sies H. Oxidative stress: excited oxygen species and enzyme activity. Adv Enzyme Regul 1985; 23: 217-37.
13. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18: 775-94.
14. 2 generation: redox signaling and oxidative stress. J Biol Chem 2014; 289: 8735-41.
15. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996; 20: 553-66.
16. Toyokuni S. Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rep 2002; 7: 189-97.
17. Cadet J, Berger M, Shaw A. The radiation chemistry of the purine bases within DNA and related model compounds. In: Simic MG, Grossman L, Upton AC, eds. Mechanisms of DNA Damage and Repair. New York: Plenum, 1986; 69-74.
18. Dizdaroglu M. Measurement of radiation-induced damage to DNA at the molecular level. Int J Radiat Biol 1992; 61: 175-83.
19. Buettner GR. Moving free radical and redox biology ahead in the next decade (s). Free Radic Biol Med 2015; 78: 236-8.
20. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274: 532-8.
21. Toyokuni S. Reactive oxygen species-induced molecular damage and its applicaton in pathology. Pathol Int 1999; 49: 91-102.
22. Ischiropoulos H, Zhu L, Chen J et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298: 431-7.
23. Uchida K, Stadtman ER. Modification of histidine residues in proteins by reaction with 4- hydroxynonenal. Proc Natl Acad Sci U S A 1992; 89: 4544-8.
24. Dizdaroglu M Chemical determination of oxidative DNA damage by gas chromatography- mass spectrometry. Methods Enzymol 1994; 234: 3-16.
25. Toyokuni S, Akatsuka S. Pathological investigation of oxidative stress in the post-genomic era. Pathol Int 2007; 57: 461-73.
26. Hirayama T, Okuda K, Nagasawa H. A highly selective turn-on fluorescent probe fro iron(II) to visualize labile iron in living cells. Chem Sci 2013; 4: 1250-6.
27. Mukaide T, Hattori Y, Misawa N et al. Histological detection of catalytic ferrous iron with the selective turn-on fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model. Free Radic Res 2014; 48: 990-5.
28. Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc 1894; 65: 899-910.
29. Grant CM, Perrone G, Dawes IW. Glutathione and Catalase Provide Overlapping Defenses for Protection against Hydrogen Peroxide in the YeastSaccharomyces cerevisiae. Biochem Biophys Res Commun 1998; 253: 893-8.
30. Flohe L, Günzler WA, Schock HH. Glutathione peroxidase: a selenoenzyme. FEBS Lett 1973; 32: 132-4.
31. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005; 38: 1543-52.
32. Jeong W, Bae SH, Toledano MB, Rhee SG. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression. Free Radic Biol Med 2012; 53: 447-56.
33. Poole LB, Karplus PA, Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 2004; 44: 325-47.
34. Saurin AT, Neubert H, Brennan JP, Eaton P. Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc Natl Acad Sci U S A 2004; 101: 17982-7.
35. Woo HA, Chae HZ, Hwang SC et al. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 2003; 300: 653-6.
36. Jacob C, Holme AL, Fry FH. The sulfinic acid switch in proteins. Org Biomol Chem 2004; 2: 1953-6.
37. Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med 2014; 66: 75-87.
38. Itoh K, Ishii T, Wakabayashi N, Yamamoto M. Regulatory mechanisms of cellular response to oxidative stress. Free Radic Res 1999; 31: 319-24.
39. Itoh K, Wakabayashi N, Katoh Y et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999; 13: 76-86.
40. Suzuki T, Motohashi H, Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 2013; 34: 340-6.
41. Ohta T, Iijima K, Miyamoto M et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 2008; 68: 1303-9.
42. Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 2012; 12: 564-71.
43. Dypbukt JM, Ankarcrona M, Burkitt M et al. Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. The role of intracellular polyamines. J Biol Chem 1994; 269: 30553-60.
44. Hiroyasu M, Akatsuka S, Shirase T, Toda Y, Hiai H, Toyokuni S. Detection of glyceraldehyde 3-phosphate dehydrogenase messenger RNA using a peptide nucleic acid probe in paraffin-embedded archival specimens. Pathol Int 2004; 54: 251-5.
45. Atherton NM, Davies MJ, Gilbert BC, eds. Electron spin resonance: A review of recent literature to 1993. Cambridge, UK: Royal Society of Chemistry, 1994.
46. Toyokuni S, Masumizu T, Ozeki M et al. An electron spin resonance study on alkylperoxyl radical in thin-sliced renal tissues from ferric nitrilotriacetate-treated rats: the effect of alpha-tocopherol feeding. Free Radic Res 2001; 35: 245-55.
47. Bates GW, Wernicke J. The kinetics and mechanism of iron (III) exchange between chelates and transferrin IV. The reaction of transferrin with iron (III) nitrilotriacetate. J Biol Chem 1971; 246: 3679-85.
48. Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate: a model of experimental hemochromatosis. Am J Pathol 1979; 95: 663-74.
49. Okada S, Midorikawa O. Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn Arch Intern Med 1982; 29: 485-91.
50. Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum- nitrilotriacetate complexes in rats. J Natl Cancer Inst 1986; 76: 107-13.
51. Li JL, Okada S, Hamazaki S, Ebina Y, Midorikawa O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 1987; 47: 1867-9.
52. Hamazaki S, Okada S, Ebina Y, Midorikawa O. Acute renal failure and glucosuria induced by ferric nitrilotriacetate in rats. Toxicol Appl Pharmacol 1985; 77: 267-74.
53. Hamazaki S, Okada S, Ebina Y, Fujioka M, Midorikawa O. Nephrotoxicity of ferric nitrilotriacetate: an electron-microscopic and metabolic study. Am J Pathol 1986; 123: 343-50.
54. Okada S, Hamazaki S, Ebina Y, Li J-L, Midorikawa O. Nephrotoxicity and its prevention by vitamin E on ferric nitrilotriacetate-promoted lipid peroxidation. Biochim Biophys Acta 1987; 922: 28-33.
55. Pompella A, Maellaro E, Casini AF, Comporti M. Histochemical detection of lipid peroxidation in the liver of bromobenzene-poisoned mice. Am J Pathol 1987; 129: 295-301.
56. Pompella A, Romani A, Fulceri R, Benedetti A, Comporti M. 4-Hydroxynonenal and other lipid peroxidation products are formed in mouse liver following intoxication with allyl alcohol. Biochim Biophys Acta 1988; 961: 293-8.
57. Toyokuni S, Okada S, Hamazaki S et al. Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice. Cancer Res 1990; 50: 5574-80.
58. Okada S, Fukunaga Y, Hamazaki S, Yamada Y, Toyokuni S. Sex differences in the localization and severity of ferric nitrilotriacetate-induced lipid peroxidation in the mouse kidney. Acta Pathol Jpn 1991; 41: 221-6.
59. Okada S Iron-induced tissue damage and cancer: The role of reactive oxygen free radicals. Pathol Int 1996; 46: 311-32.
60. Stadtman ER. Protein oxidation and aging. Science 1992; 257: 1220-4.
61. Stadtman E, Levine R. Protein oxidation. Ann N Y Acad Sci 2000; 899: 191-208.
62. Toyokuni S, Mori T, Dizdaroglu M. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer 1994; 57: 123-8.
63. Toyokuni S, Mori T, Hiai H, Dizdaroglu M. Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Int J Cancer 1995; 62: 309-13.
64. 7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 1997; 22: 1019-27.
65. Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci U S A 1994; 91: 2616-20.
66. Toyokuni S, Tanaka T, Hattori Y et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 365-74.
67. Toyokuni S, Miyake N, Hiai H et al. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 1995; 359: 189-91.
68. Ihara Y, Toyokuni S, Uchida K et al. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 1999; 48: 927-32.
69. Hattori Y, Nishigori C, Tanaka T et al. 8-Hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic UVB exposure. J Invest Dermatol 1996; 107: 733-7.
70. Toyokuni S, Yasui H, Date A et al. Novel screening method for ultraviolet protection: Combination of a human skin-equivalent model and 8-hydroxy-2′-deoxyguanosine. Pathol Int 2006; 56: 760-2.
71. Matsui M, Nishigori C, Toyokuni S et al. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2′-deoxyguanosine in arsenic-related Bowen's disease. J Invest Dermatol 1999; 113: 26-31.
72. Gunshin H, Mackenzie B, Berger U et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-8.
73. Toyokuni S Role of iron in carcinogenesis: Cancer as a ferrotoxic disease. Cancer Sci 2009; 100: 9-16.
74. Vogelstein B, Kinzler KW. The Genetic Basis of Human Cancer. New York: McGraw-Hill, 1998.
75. Nishiyama Y, Suwa H, Okamoto K, Fukumoto M, Hiai H, Toyokuni S. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn J Cancer Res 1995; 86: 1150-8.
76. INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 1999; 18: 3793-7.
77. Fukuda A, Osawa T, Hitomi K, Uchida K. 4-Hydroxy-2-nonenal cytotoxicity in renal proximal tubular cells: protein modification and redox alteration. Arch Biochem Biophys 1996; 333: 419-26.
78. Satoh K, Yamada S, Koike Y, et al. A 1-hour enzyme-linked immunosorbent assay for quantitation of acrolein- and hydroxynonenal-modified proteins by epitope-bound casein matrix method. Anal Biochem 1999; 270: 323-8.
79. Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem 1999; 274: 23787-93.
80. Kawai Y, Furuhata A, Toyokuni S, Aratani Y, Uchida K. Formation of acrolein-derived 2′-deoxyadenosine adduct in an iron-induced carcinogenesis model. J Biol Chem 2003; 278: 50346-54.
81. Hashimoto M, Sibata T, Wasada H, Toyokuni S, Uchida K. Structural basis of protein-bound endogenous aldehydes. Chemical and immunochemical characterizations of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct. J Biol Chem 2003; 278: 5044-51.
82. Ozeki M, Miyagawa-Hayashino A, Akatsuka S et al. Susceptibility of actin to modification by 4-hydroxy-2-nonenal. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 827: 119-26.
83. 2-mediated covalent modification of protein by lipid peroxidation-derived saturated aldehydes. Chem Res Toxicol 2008; 21: 1261-70.
84. Okada S, Minamiyama Y, Hamazaki S, Toyokuni S, Sotomatsu A. Glutathione cycle dependency of ferric nitrilotriacetate-induced lipid peroxidation in mouse proximal renal tubules. Arch Biochem Biophys 1993; 301: 138-42.
85. Toyokuni S, Sagripanti JL. Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron. J Inorg Biochem 1992; 47: 241-8.
86. Toyokuni S, Sagripanti J-L. DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis. Carcinogenesis 1993; 14: 223-7.
87. Akatsuka S, Yamashita Y, Ohara H, et al. Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One 2012; 7 e43403.
88. Liu Y-T, Shang D-G, Akatsuka S et al. Chronic oxidative stress causes amplification and overexpresson of ptprz1 protein tyrosine phosphatase to activate b-catenin pathway. Am J Pathol 2007; 171: 1978-88.
89. Edwards JH. The Oxford Grid. Ann Hum Genet 1991; 55: 17-31.
90. Toyokuni S Mysterious link between iron overload and CDKN2A/2B. J Clin Biochem Nutr 2011; 48: 46-9.
91. Toyokuni S, Akatsuka S. What has been learned from the studies of oxidative stress-induced carcinogenesis: Proposal of the concept of oxygenomics. J Clin Biochem Nutr 2006; 39: 3-10.
92. Toyokuni S Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics. IUBMB Life 2008; 60: 441-7.
93. Aruoma, OI, Halliwell, B, eds. DNA and Free radicals: Techniques, Mechanisms and Applications. 1st edn. Saint Lucia/London: OICA International, 1998.
94. Toyokuni S, Sagripanti J-L. Association between 8-hydroxy-2′-deoxyguanosine formation and DNA strand breaks mediated by copper and iron. Free Radic Biol Med 1996; 20: 859-64.
95. Akatsuka S, Toyokuni S. Genome-scale approaches to investigate oxidative DNA damage. J Clin Biochem Nutr 2010; 47: 91-7.
96. Akatsuka S, Aung TT, Dutta KK et al. Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis. Am J Pathol 2006; 169: 1328-42.
97. Cremer T, Cremer C. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat Rev Genet 2001; 2: p292-301.
98. Tanabe H, Muller S, Neusser M et al. Evolutionary conservation of chromosome territory arrangements in cell nuclei from higher primates. Proc Natl Acad Sci U S A 2002; 99: 4424-9.
99. Yoshihara M, Jiang L, Akatsuka S, Suyama M, Toyokuni S. Genome-wide profiling of 8-oxoguanine reveals its association with spatial positioning in nucleus. DNA Res 2014; 21: 603-12.
100. Dixon SJ, Lemberg KM, Lamprecht MR et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012; 149: 1060-72.
101. Ursini F, Maiorino M, Valente M, Ferri L, Gregolin C. Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim Biophys Acta 1982; 710: 197-211.
102. Yang WS, SriRamaratnam R, Welsch ME et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014; 156: 317-31.
103. Imai H, Nakagawa Y. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med 2003; 34: 145-69.
104. Angeli JPF, Schneider M, Proneth B et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 2014; 16: 1180-91.
105. Okamoto K, Toyokuni S, Uchida K et al. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal- modified proteins in human renal-cell carcinoma. Int J Cancer 1994; 58: 825-9.
106. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995; 358: 1-3.
107. Okamoto K, Toyokuni S, Kim WJ et al. Overexpression of human mutT homologue gene messenger RNA in renal-cell carcinoma: evidence of persistent oxidative stress in cancer. Int J Cancer 1996; 65: 437-41.
108. Toyokuni S Iron as a target of chemoprevention for longevity in humans. Free Radic Res 2011; 45: 906-17.
109. Roggli, VL, Oury, TD, Sporn, TA, eds. Pathology of Asbestos-Associated Diseases. 2nd edn. New York: Springer Verlag, 2004.
110. IARC. Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite, and anthophyllite). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens; Part C: Arsenic, Metals, Fibres, and Dusts. Vol. 100C. Lyon, France: IARC 2012; 219-309.
111. Editorial. Editorials this week: Asbestos scandal. Nature 2010; 468: 868.
112. 79 Kubota workers killed by asbestos over 26 years (2005.06.30). The Daily Yomiuri. 2005.
113. Nagai H, Chew S, Okazaki Y et al. Metamorphosis of mesothelial cells wtih active horizontal motility in tissue culture. Sci Rep 2013; 3: 1144.
114. Yamashita K, Nagai H, Toyokuni S. Receptor role of annexin A2 in the mesothelial endocytosis of crocidolite fibers. Lab Invest 2015; 95: 749-64.
115. Robinson B, Lake R. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591-603.
116. Diandini R, Takahashi K, Park EK et al. Potential years of life lost (PYLL) caused by asbestos-related diseases in the world. Am J Ind Med 2013; 56: 993-1000.
117. Jiang L, Akatsuka S, Nagai H et al. Iron overload signature in chrysotile-induced malignant mesothelioma. J Pathol 2012; 228: 366-77.
118. Chew SH, Okazaki Y, Nagai H et al. Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production. Carcinogenesis 2013; 35: 164-72.
119. Cheng JQ, Jhanwar SC, Klein WM, et al. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 1994; 54: 5547-51.
120. Xio S, Li D, Vijg J, Sugarbaker DJ, Corson JM, Fletcher JA. Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene 1995; 11: 511-5.
121. Jiang L, Nagai H, Ohara H et al. Characteristics and modifying factors of asbestos-induced oxidative DNA damage. Cancer Sci 2008; 99: 2142-51.
122. Nagai H, Ishihara T, Lee WH et al. Asbestos surface provides a niche for oxidative modification. Cancer Sci 2011; 102: 2118-25.
123. Kubo Y, Takenaka H, Nagai H, Toyokuni S. Distinct affinity of nuclear proteins to the surface of chrysotile and crocidolite. J Clin Biochem Nutr 2012; 51: 221-6.
124. Toyokuni S Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci 2009; 71: 1-10.
125. Nagai H, Okazaki Y, Chew SH, Misawa N, Yasui H, Toyokuni S. Deferasirox induces mesenchymal-epithelial transition in crocidolite-induced mesothelial carcinogenesis in rats. Cancer Prev Res 2013; 6: 1222-30.
126. Jiang L, Yamashita Y, Chew SH et al. Connective tissue growth factor and β-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma. J Pathol 2014; 233: 402-14.
127. Chew SH, Toyokuni S. Malignant mesothelioma as an oxidative stress-induced cancer: An update. Free Radic Biol Med 2015; 86: 166-78.
128. Iijima S Helical Microtubules of Graphitic Carbon. Nature 1991; 354: 56-8.
129. Endo M, Strano MS, Ajayan PM. Potential applications of carbon nanotubes. In: Carbon Nanotubes. Berlin Heidelberg: Springer, 2008; 13-62.
130. Meng ZX, Zheng W, Ding MH, et al. Fabrication and characterization of elastomeric polyester/carbon nanotubes nanocomposites for biomedical application. J Nanosci Nanotechnol 2011; 11: 3126-33.
131. Poland C, Duffin R, Kinloch I et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008; 3: 423-8.
132. Nagai H, Okazaki Y, Chew S, et al. Diameter of multi-walled carbon nanotubes is a critical factor in mesothelial injury and subsequent carcinogenesis. Proc Natl Acad Sci U S A 2011; 108: E1330-8.
133. Grosse Y, Loomis D, Guyton KZ et al. Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Lancet Oncol 2014; 15: 1427-8.
134. +/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 2008; 33: 105-16.
135. Takagi A, Hirose A, Futakuchi M, Tsuda H, Kanno J. Dose-dependent mesothelioma induction by intraperitoneal administration of multi-wall carbon nanotubes in p53 heterozygous mice. Cancer Sci 2012; 103: 1440-4.
136. Sakamoto Y, Nakae D, Fukumori N et al. Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J Toxicol Sci 2009; 34: 65-76.
137. Nagai H, Okazaki Y, Chew SH, et al. Intraperitoneal administration of tangled multiwalled carbon nanotubes of 15 nm in diameter does not induce mesothelial carcinogenesis in rats. Pathol Int 2013; 63: 457-62.
138. Toyokuni S Genotoxicity and carcinogenicity risk of carbon nanotubes. Adv Drug Deliv Rev 2013; 65: 2098-110.
139. Toyokuni S, Jiang LI, Kitaura R, Shinohara H. Minimal inflammogenicity of pristine single-wall carbon nanotubes. Nagoya J Med Sci 2015; 77: 195.
140. Wang Y, Okazaki Y, Shi L, et al. Role of hemoglobin and transferrin in multi-wall carbon nanotube-induced mesothelial injury and carcinogenesis. Cancer Sci 2016 in press. doi: 10.1111/cas.12865.
141. Funahashi S, Okazaki Y, Ito D et al. Asbestos and multi-walled carbon nanotubes generate distinct oxidative responses in inflammatory cells. J Clin Biochem Nutr 2015; 56: 111-7.
142. Fridman G, Friedman G, Gutsol A, Shekhter AB, Vasilets VN, Fridman A. Applied plasma medicine. Plasma Processes Polym 2008; 5: 503-33.
143. Kalghatgi S, Kelly CM, Cerchar E et al. Effects of non-thermal plasma on mammalian cells. PLoS One 2011; 6 e16270.
144. Tanaka H, Mizuno M, Toyokuni S, et al. Cancer therapy using non-thermal atmospheric pressure plasma with ultra-high electron density. Phys Plasmas 2015; 22: 122004.
145. Okazaki Y, Wang Y, Tanaka H, et al. Direct exposure of non-equilibrium atmospheric pressure plasma confers simultaneous oxidative and ultraviolet modifications in biomolecules. J Clin Biochem Nutr 2014; 55: 207.
146. Isbary G, Morfill G, Schmidt HU et al. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol 2010; 163: 78-82.
147. Iseki S, Nakamura K, Hayashi M et al. Selective killing of ovarian cancer cells through induction of apoptosis by nonequilibrium atmospheric pressure plasma. Appl Phys Lett 2012; 100: 113702.
148. Utsumi F, Kajiyama H, Nakamura K et al. Effect of Indirect Nonequilibrium Atmospheric Pressure Plasma on Anti-Proliferative Activity against Chronic Chemo-Resistant Ovarian Cancer Cells In Vitro and In Vivo. PLoS One 2013; 8 e81576.
149. Ye F, Kaneko H, Nagasaka Y et al. Plasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degeneration. Sci Rep 2015; 5: 7705.
150. Tanaka H, Mizuno M, Ishikawa K et al. Plasma-activated medium selectively kills glioblastoma brain tumor cells by down-regulating a survival signaling molecule, AKT kinase. Plasma Med 2011; 1: 265-77.